eGenesis
eGenesis is a biotechnology company developing human-compatible organs and tissues through gene editing to address organ shortages. The company has raised $456 million, including a Series D round in September 2024, and employs 155 people.
The growth story
eGenesis grew from 113 to 155 employees between 2023 and 2026, raising $456M along the way, most recently a Series D in September 2024.
About
eGenesis uses advanced gene-editing techniques to create organs and tissues that are compatible with human transplantation. Its focus is on overcoming virology and immunology challenges in xenotransplantation, aiming to provide scalable alternatives to traditional organ transplants.
The company has secured $456 million in funding, with its latest Series D round closing in September 2024. Its workforce of 155 is primarily focused on research, with 21 employees dedicated to this function.
Founders and leadership
eGenesis is led by a team focused on biotechnology and gene editing, with research being the largest function, employing 21 people. The company operates from its headquarters in Cambridge, Massachusetts.
The eGenesis org chart
Michael Curtis (President and CEO) leads 46 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 36 (+13% YoY), Healthcare Services 23 (+21% YoY), Operations 19 (+12% YoY), Community and Social Services 16 (+14% YoY), Business Development 13 (-7% YoY), Quality Assurance 12 (+20% YoY).
Talent flow
eGenesis recruits heavily from Purdue University, with 6 alumni joining the company. Other notable sources include Pfizer, Boston Children's Hospital, and the University of Wisconsin-Madison. Alumni often move to companies like Takeda, Vertex Pharmaceuticals, and AstraZeneca.
Most common previous employers of eGenesis staff: Purdue University (6), Pfizer (4), Boston Children's Hospital (4), University of Wisconsin-Madison (4), Novartis (3), Merck (3). Former eGenesis employees most often moved to Takeda (3), Vertex Pharmaceuticals (3), AstraZeneca (2), LabNestUs (2), nChroma Bio (2), Regeneron (2).
Alumni worth knowing
The eGenesis mafia
eGenesis alumni have founded several companies, including Alentis Therapeutics, Fable Therapeutics, and LabNestUs. These ventures collectively employ over 100 people, showcasing the entrepreneurial impact of eGenesis talent.
7Mark Pruzanski, MA, MD, was Board Member until 2024Geoff MacKay, was Founding CEO / Managing Director until 2017David A., was Computational Biologist II until 2021Haydy George, MD, was Research Operations & Laboratory Manager until 2019Jurgen Poci, was Research Assistant until 2016Peter Hanson, was Chief Operating Officer until 2023
Russell Ernst, Ph.D., was Associate Director until 2023Hiring now
Web traffic
Traffic mix: 30% direct, 70% search, 0% social, 0% paid.
What this company is made of
Most common skills at eGenesis: Microsoft Office (39), Research Skills (32), Leadership (31), Microsoft Excel (29), Biotechnology (29), Communication (28), Data Analysis (28), Cell Culture (24).
Where the team actually sits
eGenesis people are concentrated in Massachusetts, United States (35), Wisconsin, United States (14), Greater Boston (13), United States (11).
Search footprint
eGenesis attracts about 313 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 15 ranking keywords and lost 41 in the last period.
What employees say
- Compensation
- 3.40 / 5
- Career opportunities
- 3.80 / 5
- Senior management
- 3.50 / 5
- Work-life balance
- 3.50 / 5
Frequently asked
eGenesis has 155 employees as of September 2026.
eGenesis has raised $456M in total, most recently a Series D round in September 2024.
eGenesis was founded in 2015 by George Church.
Michael Curtis (President and CEO) sits at the top of eGenesis's reporting structure, with 5 direct reports.
The most common previous employers of current eGenesis staff are Purdue University (6 people), Pfizer (4 people), Boston Children's Hospital (4 people).
Former eGenesis employees most often move to Takeda (3), Vertex Pharmaceuticals (3), AstraZeneca (2).
At least 6 companies have a founder who previously worked at eGenesis, including Alentis Therapeutics, Fable Therapeutics, The Organogenesis and Tissue Replacement Lab.
eGenesis attracts about 313 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among eGenesis staff are Microsoft Office, Research Skills, Leadership, Microsoft Excel, Biotechnology.
eGenesis staff are concentrated in Massachusetts, United States (35), Wisconsin, United States (14), Greater Boston (13).
eGenesis has about 36 people in Research, up 13% over the past year, as of September 2026.
eGenesis has about 23 people in Healthcare Services, up 21% over the past year, as of September 2026.
Computed from 92 current and 129 former eGenesis profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.